KS-Biologics Revenue

Pharmaceutical Manufacturing • #A-2004 Geumgang Penterium IT Tower, 282 Hagui-ro, Korea, Republic of • 1-10 Employees

KS-Biologics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at KS-Biologics

Sung-Seup Shin

Senior Managing Director

Company overview

Headquarters	#A-2004 Geumgang Penterium IT Tower, 282 Hagui-ro, #A-2004, Dongan-gu, Anyang-si, Gyeonggi-do 14056, KR
Website	ks-biologics.com
NAICS	3254
Keywords	Cmo/Cdmo, Cytotoxic Injection, Oncology Generic Manufacturing
Founded	2023
Employees	1-10

About KS-Biologics

KSBL is dedicated to lead the field of nano-medicine by continuously seeking ways for innovative research and development. Established in 2023, KSBL is a pharmaceutical company based in South Korea and a joint venture between SN BioScience and KUKJEON. Leveraging our expertise in oncological production, we strive to develop cutting-edge nano-carriers for precise delivery. Our product pipeline aims to include various generics of cytotoxic injection to treat variety of cancers. We are also committed to exporting our technologies to other countries, to ensure global access of our groundbreaking solutions

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

KS-Biologics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

KS-Biologics has never raised funding before.

Frequently asked questions

KS-Biologics is located in #A-2004 Geumgang Penterium IT Tower, 282 Hagui-ro, KR.

KS-Biologics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

KS-Biologics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

KS-Biologics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

KS-Biologics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at KS-Biologics

Sung-Seup Shin

Senior Managing Director

4.8

40,000 users